Literature DB >> 21989147

Endoscopic ultrasound-guided fine needle aspiration biopsy for diagnosis of lymphoproliferative disorders: feasibility of immunohistological, flow cytometric, and cytogenetic assessments.

Ichiro Yasuda1, Naoe Goto, Hisashi Tsurumi, Masanori Nakashima, Shinpei Doi, Takuji Iwashita, Nobuhiro Kanemura, Senji Kasahara, Seiji Adachi, Takeshi Hara, Masahito Shimizu, Tsuyoshi Takami, Hisataka Moriwaki.   

Abstract

OBJECTIVES: In addition to morphology, immunophenotype and genetic abnormalities should be assessed during diagnosis and subclassification of lymphoproliferative disorders. The objective of this study was to evaluate the yield of endoscopic ultrasound-guided fine needle aspiration biopsy (EUS-FNAB) using a standard 19-gauge needle for diagnosis and subclassification of lymphoma, assessing the feasibility of immunohistological, flow cytometric, and cytogenetic assessments.
METHODS: Two hundred forty patients with suspected lymphoma were referred for EUS-FNAB to our quaternary EUS center between June 2005 and December 2010. EUS-FNAB using a conventional 19-gauge needle was attempted for all patients, followed by histological assessments including immunohistological staining, flow cytometry, and cytogenetic analysis (G-band karyotyping). Among the patients, 152 were ultimately diagnosed with lymphoma. The primary outcome measure of this study was the sensitivity of histological assessment, including immunohistological staining, flow cytometry, and G-band karyotyping, for diagnosis and subclassification of lymphoma.
RESULTS: Among the 152 patients ultimately diagnosed with lymphoma, 147 patients (96.7%) were diagnosed by EUS-FNAB, and classification in accordance with the WHO (World Health Organization) system was also possible for 135 patients (88.8%) on the basis of histological findings, including immunohistological staining. Flow cytometry showed abnormal or unusual cell populations in 121 (79.6%) of the 152 patients diagnosed with lymphoma, and in 114 (90.5%) of the 126 patients diagnosed with B-cell lymphoma. Specific cytogenetic abnormalities were detected in 21 (13.8%) of the lymphoma patients.
CONCLUSIONS: EUS-FNAB using a standard 19-gauge needle has high diagnostic value for lymphoma. Immunophenotyping is usually possible, while cytogenetic abnormalities can be identified in a relatively limited number of patients.

Entities:  

Mesh:

Year:  2011        PMID: 21989147     DOI: 10.1038/ajg.2011.350

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  31 in total

Review 1.  [Role of cytology in hematopathological diagnostics].

Authors:  B Bode; M Tinguely
Journal:  Pathologe       Date:  2012-07       Impact factor: 1.011

Review 2.  Ultrasound techniques in the evaluation of the mediastinum, part I: endoscopic ultrasound (EUS), endobronchial ultrasound (EBUS) and transcutaneous mediastinal ultrasound (TMUS), introduction into ultrasound techniques.

Authors:  Christoph Frank Dietrich; Jouke Tabe Annema; Paul Clementsen; Xin Wu Cui; Mathias Maximilian Borst; Christian Jenssen
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

Review 3.  Ultrasound techniques in the evaluation of the mediastinum, part 2: mediastinal lymph node anatomy and diagnostic reach of ultrasound techniques, clinical work up of neoplastic and inflammatory mediastinal lymphadenopathy using ultrasound techniques and how to learn mediastinal endosonography.

Authors:  Christian Jenssen; Jouke Tabe Annema; Paul Clementsen; Xin-Wu Cui; Mathias Maximilian Borst; Christoph Frank Dietrich
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

Review 4.  Endoscopic ultrasound guided fine needle aspiration and useful ancillary methods.

Authors:  Mario Tadic; Tajana Stoos-Veic; Rajko Kusec
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

5.  Diagnostic ability of a 22G Franseen needle in endoscopic ultrasound-guided fine needle aspiration of subepithelial lesions.

Authors:  Akashi Fujita; Shomei Ryozawa; Masanori Kobayashi; Ryuichiro Araki; Koji Nagata; Kazuhiro Minami; Yuki Tanisaka; Tsutomu Kobatake; Masafumi Mizuide
Journal:  Mol Clin Oncol       Date:  2018-09-03

6.  What Is the Appropriate Sample Size One Should Submit from EUS Biopsies for Genotyping Lymphomas? Ask Your Pathologist before Embarking.

Authors:  Jerome H Siegel; William H Brown; Franklin E Kasmin
Journal:  Am J Gastroenterol       Date:  2016-06       Impact factor: 10.864

7.  Feasibility of Using an Enzymatically Activatable Fluorescence Probe for the Rapid Evaluation of Pancreatic Tissue Obtained Using Endoscopic Ultrasound-Guided Fine Needle Aspiration: a Pilot Study.

Authors:  Kazumichi Kawakubo; Shunsuke Ohnishi; Yutaka Hatanaka; Kanako C Hatanaka; Hidetaka Hosono; Yoshimasa Kubota; Mako Kamiya; Masaki Kuwatani; Hiroshi Kawakami; Yasuteru Urano; Naoya Sakamoto
Journal:  Mol Imaging Biol       Date:  2016-06       Impact factor: 3.488

8.  Endoscopic Ultrasound-Guided Fine Needle Biopsy Using 22-Gauge Franseen Needle for the Histological Diagnosis of Solid Lesions: A Multicenter Prospective Pilot Study.

Authors:  Naoki Mita; Takuji Iwashita; Shinya Uemura; Yuhei Iwasa; Katsuhisa Toda; Tsuyoshi Mukai; Tatsuhiko Miyazaki; Ichiro Yasuda; Masahito Shimizu
Journal:  Dig Dis Sci       Date:  2019-09-18       Impact factor: 3.199

9.  A case of primary pancreatic lymphoblastic lymphoma diagnosed by endoscopic ultrasound-guided fine-needle aspiration.

Authors:  So Nakaji; Nobuto Hirata; Toshiyasu Shiratori; Masayoshi Kobayashi; Hiroyuki Fujii; Eiji Ishii; Kosei Matsue; Kazuei Hoshi
Journal:  Clin J Gastroenterol       Date:  2014-03-15

10.  Slow pull versus suction in endoscopic ultrasound-guided fine-needle aspiration of pancreatic solid masses.

Authors:  Yousuke Nakai; Hiroyuki Isayama; Kenneth J Chang; Natsuyo Yamamoto; Tsuyoshi Hamada; Rie Uchino; Suguru Mizuno; Koji Miyabayashi; Keisuke Yamamoto; Kazumichi Kawakubo; Hirofumi Kogure; Takashi Sasaki; Kenji Hirano; Mariko Tanaka; Minoru Tada; Masashi Fukayama; Kazuhiko Koike
Journal:  Dig Dis Sci       Date:  2014-01-16       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.